Related Articles
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1
Transforming growth factor‑β, insulin‑like growth factor I/insulin‑like growth factor I receptor and vascular endothelial growth factor‑A: Prognostic and predictive markers in triple‑negative and non‑triple‑negative breast cancer
Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner
Association between transforming growth factor-β1 expression and the clinical features of triple negative breast cancer